{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:20:52Z","timestamp":1791829252071,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>COVID\u201019 patients can develop clinical and histopathological features associated with fibrosis, but the pathogenesis of fibrosis remains poorly understood. CD147 has been identified as a universal receptor for SARS-CoV-2 and its variants, which could initiate COVID-19-related cytokine storm. Here, we systemically analyzed lung pathogenesis in SARS-CoV-2- and its delta variant-infected humanized CD147 transgenic mice. Histopathology and Transmission Electron Microscopy revealed inflammation, fibroblast expansion and pronounced fibrotic remodeling in SARS-CoV-2-infected lungs. Consistently, RNA-sequencing identified a set of fibrosis signature genes. Furthermore, we identified CD147 as a crucial regulator for fibroblast activation induced by SARS-CoV-2. We found conditional knockout of CD147 in fibroblast suppressed activation of fibroblasts, decreasing susceptibility to bleomycin-induced pulmonary fibrosis. Meplazumab, a CD147 antibody, was able to inhibit the accumulation of activated fibroblasts and the production of ECM proteins, thus alleviating the progression of pulmonary fibrosis caused by SARS-CoV-2. In conclusion, we demonstrated that CD147 contributed to SARS-CoV-2-triggered progressive pulmonary fibrosis and identified CD147 as a potential therapeutic target for treating patients with post-COVID-19 pulmonary fibrosis.<\/jats:p>","DOI":"10.1038\/s41392-022-01230-5","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:04:22Z","timestamp":1669352662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Jiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-1232","authenticated-orcid":false,"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Xuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-7115","authenticated-orcid":false,"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-4622","authenticated-orcid":false,"given":"Huijie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","volume":"9","author":"MF Osuchowski","year":"2021","unstructured":"Osuchowski, M. F. et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir. Med. 9, 622\u2013642 (2021).","journal-title":"Lancet Respir. Med."},{"key":"1230_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323, 2052\u20132059 (2020).","journal-title":"JAMA"},{"key":"1230_CR3","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1007\/s00330-020-06975-7","volume":"30","author":"V Ojha","year":"2020","unstructured":"Ojha, V., Mani, A., Pandey, N. N., Sharma, S. & Kumar, S. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur. Radio. 30, 6129\u20136138 (2020).","journal-title":"Eur. Radio."},{"key":"1230_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"1230_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla, G. et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir. Res. 19, 32 (2018).","journal-title":"Respir. Res."},{"key":"1230_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George, P. M., Wells, A. U. & Jenkins, R. G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir. Med. 8, 807\u2013815 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1230_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","volume":"184","author":"X Nie","year":"2021","unstructured":"Nie, X. et al. Multi-organ proteomic landscape of COVID-19 autopsies. Cell 184, 775\u2013791 e714 (2021).","journal-title":"Cell"},{"key":"1230_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target Ther. 5, 283 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1230_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41392-021-00760-8","volume":"6","author":"J Geng","year":"2021","unstructured":"Geng, J. et al. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. Signal Transduct. Target Ther. 6, 347 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1230_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00428-020-02934-1","volume":"478","author":"E Barisione","year":"2021","unstructured":"Barisione, E. et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 478, 471\u2013485 (2021).","journal-title":"Virchows Arch."},{"key":"1230_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"1230_CR12","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","volume":"184","author":"D Wendisch","year":"2021","unstructured":"Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184, 6243\u20136261.e6227 (2021).","journal-title":"Cell"},{"key":"1230_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","volume":"33","author":"S Tian","year":"2020","unstructured":"Tian, S. et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod. Pathol. 33, 1007\u20131014 (2020).","journal-title":"Mod. Pathol."},{"key":"1230_CR14","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/nsr\/nwaa123","volume":"7","author":"XW Bian","year":"2020","unstructured":"Bian, X. W. & Team, C.-P. Autopsy of COVID-19 patients in China. Natl Sci. Rev. 7, 1414\u20131418 (2020).","journal-title":"Natl Sci. Rev."},{"key":"1230_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829\u2013838 (2020).","journal-title":"Kidney Int."},{"key":"1230_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"1230_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","volume":"55","author":"S Kolahian","year":"2016","unstructured":"Kolahian, S., Fernandez, I. E., Eickelberg, O. & Hartl, D. Immune mechanisms in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 55, 309\u2013322 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1230_CR18","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn, T. A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339\u20131350 (2011).","journal-title":"J. Exp. Med."},{"key":"1230_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.0707504","volume":"83","author":"IG Luzina","year":"2008","unstructured":"Luzina, I. G., Todd, N. W., Iacono, A. T. & Atamas, S. P. Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 83, 237\u2013244 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"1230_CR20","doi-asserted-by":"publisher","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","volume":"281","author":"MP Keane","year":"2001","unstructured":"Keane, M. P., Belperio, J. A., Burdick, M. D. & Strieter, R. M. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L92\u2013L97 (2001).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1230_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.taap.2013.11.012","volume":"275","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL\/6 mice. Toxicol. Appl Pharm. 275, 62\u201372 (2014).","journal-title":"Toxicol. Appl Pharm."},{"key":"1230_CR22","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","volume":"187","author":"S Mi","year":"2011","unstructured":"Mi, S. et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J. Immunol. 187, 3003\u20133014 (2011).","journal-title":"J. Immunol."},{"key":"1230_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu, H. H. et al. New insights into TGF-beta\/Smad signaling in tissue fibrosis. Chem. Biol. Interact. 292, 76\u201383 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"1230_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-beta: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1230_CR25","doi-asserted-by":"crossref","unstructured":"Kolb, P. et al. The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur. Respir. J. 55, 1901105 (2020).","DOI":"10.1183\/13993003.01105-2019"},{"key":"1230_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","volume":"1627","author":"T Liu","year":"2017","unstructured":"Liu, T., De Los Santos, F. G. & Phan, S. H. The bleomycin model of pulmonary fibrosis. Methods Mol. Biol. 1627, 27\u201342 (2017).","journal-title":"Methods Mol. Biol."},{"key":"1230_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan, S. et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat. Med. 24, 1121\u20131127 (2018).","journal-title":"Nat. Med."},{"key":"1230_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jhep.2012.07.042","volume":"57","author":"DW Zhang","year":"2012","unstructured":"Zhang, D. W. et al. HAb18G\/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis. J. Hepatol. 57, 1283\u20131291 (2012).","journal-title":"J. Hepatol."},{"key":"1230_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep16552","volume":"5","author":"HY Li","year":"2015","unstructured":"Li, H. Y. et al. Activation of TGF-beta1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis. Sci. Rep. 5, 16552 (2015).","journal-title":"Sci. Rep."},{"key":"1230_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-6-20","volume":"6","author":"DL Clarke","year":"2013","unstructured":"Clarke, D. L., Carruthers, A. M., Mustelin, T. & Murray, L. A. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogenes. Tissue Repair. 6, 20 (2013).","journal-title":"Fibrogenes. Tissue Repair."},{"key":"1230_CR31","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.jbc.2021.100987","volume":"297","author":"EL Woods","year":"2021","unstructured":"Woods, E. L. et al. CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-beta1. J. Biol. Chem. 297, 100987 (2021).","journal-title":"J. Biol. Chem."},{"key":"1230_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1164\/rccm.200311-1535OC","volume":"171","author":"WE Lawson","year":"2005","unstructured":"Lawson, W. E. et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 171, 899\u2013907 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1230_CR33","doi-asserted-by":"crossref","unstructured":"Wollin, L. et al. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur. Respir. J. 54, 1900161 (2019).","DOI":"10.1183\/13993003.00161-2019"},{"key":"1230_CR34","doi-asserted-by":"publisher","first-page":"550955","DOI":"10.3389\/fphar.2020.550955","volume":"11","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice. Front. Pharm. 11, 550955 (2020).","journal-title":"Front. Pharm."},{"key":"1230_CR35","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/nsr\/nwaa247","volume":"7","author":"Q Liu","year":"2020","unstructured":"Liu, Q. et al. Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases. Natl Sci. Rev. 7, 1868\u20131878 (2020).","journal-title":"Natl Sci. Rev."},{"key":"1230_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420\u2013422 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1230_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41422-020-0318-5","volume":"30","author":"XH Yao","year":"2020","unstructured":"Yao, X. H. et al. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res. 30, 541\u2013543 (2020).","journal-title":"Cell Res."},{"key":"1230_CR38","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7\u2009months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).","journal-title":"EClinicalMedicine"},{"key":"1230_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259\u2013264 (2021).","journal-title":"Nature"},{"key":"1230_CR40","doi-asserted-by":"publisher","first-page":"717194","DOI":"10.3389\/fmed.2021.717194","volume":"8","author":"F Zhou","year":"2021","unstructured":"Zhou, F. et al. Assessment of sequelae of COVID-19 nearly 1\u2009year after diagnosis. Front. Med. (Lausanne) 8, 717194 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"1230_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijid.2021.05.055","volume":"108","author":"Y Umemura","year":"2021","unstructured":"Umemura, Y. et al. Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study. Int J. Infect. Dis. 108, 454\u2013460 (2021).","journal-title":"Int J. Infect. Dis."},{"key":"1230_CR42","first-page":"e14961","volume":"75","author":"M Acat","year":"2021","unstructured":"Acat, M., Yildiz Gulhan, P., Oner, S. & Turan, M. K. Comparison of pirfenidone and corticosteroid treatments at the COVID-19 pneumonia with the guide of artificial intelligence supported thoracic computed tomography. Int J. Clin. Pr. 75, e14961 (2021).","journal-title":"Int J. Clin. Pr."},{"key":"1230_CR43","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 18, 1094\u20131099 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1230_CR44","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1230_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2101643","volume":"385","author":"PO Guimaraes","year":"2021","unstructured":"Guimaraes, P. O. et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med. 385, 406\u2013415 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1230_CR46","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","volume":"8","author":"P Spagnolo","year":"2020","unstructured":"Spagnolo, P. et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir. Med. 8, 750\u2013752 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1230_CR47","doi-asserted-by":"crossref","unstructured":"Combet, M., Pavot, A., Savale, L., Humbert, M. & Monnet, X. Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19. Eur. Respir. J. 56, 2001808 (2020).","DOI":"10.1183\/13993003.01808-2020"},{"key":"1230_CR48","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.bbadis.2014.06.008","volume":"1842","author":"JJ Geng","year":"2014","unstructured":"Geng, J. J. et al. Enhancement of CD147 on M1 macrophages induces differentiation of Th17 cells in the lung interstitial fibrosis. Biochim Biophys. Acta 1842, 1770\u20131782 (2014).","journal-title":"Biochim Biophys. Acta"},{"key":"1230_CR49","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/onc.2016.89","volume":"35","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. Regulation of a TGF-beta1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. Oncogene 35, 5468\u20135479 (2016).","journal-title":"Oncogene"},{"key":"1230_CR50","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1038\/onc.2011.149","volume":"30","author":"J Wu","year":"2011","unstructured":"Wu, J. et al. HAb18G\/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug. Oncogene 30, 4410\u20134427 (2011).","journal-title":"Oncogene"},{"key":"1230_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12931-016-0334-7","volume":"17","author":"NA Hasaneen","year":"2016","unstructured":"Hasaneen, N. A., Cao, J., Pulkoski-Gross, A., Zucker, S. & Foda, H. D. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts. Respir. Res 17, 17 (2016).","journal-title":"Respir. Res"},{"key":"1230_CR52","doi-asserted-by":"publisher","first-page":"L1026","DOI":"10.1152\/ajplung.00183.2003","volume":"285","author":"V Ruiz","year":"2003","unstructured":"Ruiz, V. et al. Unbalanced collagenases\/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1026\u2013L1036 (2003).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1230_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.00060708","volume":"33","author":"S McKeown","year":"2009","unstructured":"McKeown, S., Richter, A. G., O\u2019Kane, C., McAuley, D. F. & Thickett, D. R. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 33, 77\u201384 (2009).","journal-title":"Eur. Respir. J."},{"key":"1230_CR54","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1097\/CCM.0b013e3181a5506c","volume":"37","author":"CM O\u2019Kane","year":"2009","unstructured":"O\u2019Kane, C. M. et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit. Care Med. 37, 2242\u20132249 (2009).","journal-title":"Crit. Care Med."},{"key":"1230_CR55","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/ATVBAHA.114.305115","volume":"35","author":"M Shen","year":"2015","unstructured":"Shen, M. et al. Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm. Arterioscler Thromb. Vasc. Biol. 35, 888\u2013898 (2015).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1230_CR56","doi-asserted-by":"publisher","first-page":"13763","DOI":"10.1074\/jbc.M114.622274","volume":"290","author":"C Dayer","year":"2015","unstructured":"Dayer, C. & Stamenkovic, I. Recruitment of matrix metalloproteinase-9 (MMP-9) to the fibroblast cell surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-beta (TGF-beta) activation and fibroblast differentiation. J. Biol. Chem. 290, 13763\u201313778 (2015).","journal-title":"J. Biol. Chem."},{"key":"1230_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/prot.10389","volume":"52","author":"R Chen","year":"2003","unstructured":"Chen, R., Li, L. & Weng, Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins 52, 80\u201387 (2003).","journal-title":"Proteins"},{"key":"1230_CR58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/prot.10460","volume":"53","author":"L Li","year":"2003","unstructured":"Li, L., Chen, R. & Weng, Z. RDOCK: refinement of rigid-body protein docking predictions. Proteins 53, 693\u2013707 (2003).","journal-title":"Proteins"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01230-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:04:30Z","timestamp":1669352670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01230-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01230-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}